4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-20-000003
Options or other derivatives
- CEO acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-06 | Grant or award : show line 1 in the form Warrants | +200,000 | 200,000 | I |
Loading xslF345X03/primary_doc.xml…